# A Study to Evaluate the Efficacy of ELAPR in Women With Striae Distensae Alba

> **NCT02510768** · PHASE1 · COMPLETED · sponsor: **Elastagen Pty Ltd** · enrollment: 26 (actual)

## Conditions studied

- Striae Distensae

## Interventions

- **DEVICE:** ELAPR002f
- **DEVICE:** ELAPR002g
- **DEVICE:** Saline

## Key facts

- **NCT ID:** NCT02510768
- **Lead sponsor:** Elastagen Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-16
- **Primary completion:** 2017-10-03
- **Final completion:** 2018-03-06
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2018-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02510768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02510768, "A Study to Evaluate the Efficacy of ELAPR in Women With Striae Distensae Alba". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02510768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*